FIRST HAWAIIAN BANK - BIOCRYST PHARMACEUTICALS INC ownership

BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 194 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.06 and the average weighting 0.2%.

Quarter-by-quarter ownership
FIRST HAWAIIAN BANK ownership history of BIOCRYST PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$841,000
+97.4%
51,735
+68.2%
0.03%
+100.0%
Q4 2021$426,000
-3.6%
30,7650.0%0.01%
-27.8%
Q3 2021$442,000
-32.6%
30,765
-25.9%
0.02%
-33.3%
Q2 2021$656,000
+44.5%
41,510
-7.0%
0.03%
+35.0%
Q1 2021$454,000
-2.2%
44,620
-28.4%
0.02%
-4.8%
Q4 2020$464,000
+107.1%
62,280
-4.3%
0.02%
+90.9%
Q3 2020$224,00065,0900.01%
Other shareholders
BIOCRYST PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Burrage Capital Management LLC 1,105,673$8,237,0006.28%
Sarissa Capital Management LP 8,175,000$60,903,0006.22%
ORACLE INVESTMENT MANAGEMENT INC 2,980,870$22,207,0002.78%
DG Capital Management, LLC 1,075,732$8,014,0001.70%
Ghost Tree Capital, LLC 900,000$6,705,0001.49%
Parkman Healthcare Partners LLC 538,370$4,011,0001.03%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 5,835,810$43,477,0000.86%
Formidable Asset Management, LLC 470,419$3,470,0000.80%
KNOTT DAVID M 219,461$1,635,0000.74%
Altium Capital Management LP 250,000$1,863,0000.70%
View complete list of BIOCRYST PHARMACEUTICALS INC shareholders